Thermo Fisher Scientific Inc. (TMO)
Last Price$523.6(1.0%)
Market Cap$201.0B
TMO Rating
TMO Quality rating performance
TMO Intrinsic Value
Key Highlights:
As of Mar 03, 2025 TMO Relative Value is $651.5, which is undervalued by 24.4%, compared to current share price of $523.6.
As of Mar 03, 2025 TMO DCF Value is $557.2, which is undervalued by 6.4%, compared to current share price of $523.6.
TMO Share Price History
1W (2.2%)
1M (11.8%)
6M (13.5%)
YTD (3.5%)
1Y (9.7%)
3Y (4.8%)
5Y 70.8%
10Y 315.9%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
TMO Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$201.0B
$226.7B
$42.9B
$7,267.0M
Shares Outstanding
384M
Employees
N/A
Growth (CAGR)
10.9%
12.42%
12.4%
(0.2%)
39.77%
Profitability
41.5%
17.1%
14.8%
20.2%
16.9%
114.7%
Intrinsic Value
$602.4 (15.0% undervalued)
$557.3
$647.5
$370.3
$665.5
43.2%
Return on Capital
Financial Health
$5,570.0M
$25.7B
3.5x
9.7x
63.1%
Dividends
15.8%
0.3%
8.0%
Dec 13, 2024
Earnings
Apr 22, 2025
MISS by (0.3%)
BEAT by 0.6%
(11.1%)
9 Beat & 1 Miss
TMO Stock Financials
TMO Income Statement Metrics
Annual
Quarterly
LTM
TMO Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$8,406.0M -8.2% YoY
Capital Expenditure (CAPEX)
($1,479.0M) -34.1% YoY
Free Cash Flow (FCF)
$6,927.0M +0.2% YoY
TMO Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$42.9B (4.6%) YoY
Cost of revenue
$25.7B 1.3% YoY
Pre-tax income
$6,298.0M (19.6%) YoY
14.7% margin
TMO Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$98.7B
Current assets ($24.6B, 24.9% of total)
$8,077.0M (8.2%)
$9,664.0M (9.8%)
Other current assets
$6,848.0M (6.9%)
Non-current assets ($74.1B, 75.1% of total)
$45.0M (0.0%)
$9,448.0M (9.6%)
$16.7B (16.9%)
Other non-current assets
$48.0B (48.6%)
Financial position
$26.8B
Cash & Short-term
Investments
Total Debt
TMO Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
TMO Earnings Surprises
Crunching data... Almost there!
TMO Dividends
TMO Dividend Yield
Crunching data... Almost there!
TMO Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with TMO
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$201.0B | 6.5 | $602.4 15.0% undervalued | (9.7%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 8.3% | 63.1% | |
$151.3B | 6.1 | $167.0 18.8% overvalued | (19.4%) | $23.9B | $5,296.0M | (0.1%) | 22.2% | 59.5% | 5.9% | 32.3% | |
$36.5B | 7.4 | $103.7 17.9% overvalued | (11.0%) | $6,533.0M | $1,409.0M | (3.0%) | 21.6% | 65.9% | 14.7% | 55.8% | |
$36.1B | 7.2 | $219.3 49.8% overvalued | (23.5%) | $3,897.5M | $798.1M | 6.5% | 20.5% | 61.1% | 49.4% | 6.3% | |
$33.7B | 6.1 | $301.3 63.0% undervalued | (26.5%) | $15.4B | $2,114.0M | 2.5% | 13.7% | 31.4% | 8.8% | 21.7% | |
$27.1B | 7.0 | $869.6 31.5% overvalued | (1.4%) | $3,872.4M | $864.4M | 2.2% | 22.3% | 59.1% | 49.8% | (1,587.1%) | |
$22.2B | 6.5 | $236.1 36.5% overvalued | 7.2% | $2,958.4M | $619.6M | 0.1% | 20.9% | 58.2% | 19.4% | 0.0% | |
$21.2B | 6.1 | $621.0 144.4% undervalued | 17.1% | $13.0B | $1,095.9M | 0.8% | 8.4% | 26.9% | 6.0% | 24.1% | |
$19.6B | 6.0 | $369.8 109.0% undervalued | 44.2% | $9,872.0M | $909.0M | 6.7% | 9.2% | 32.4% | 8.8% | 102.2% | |
$18.5B | 6.0 | $70.9 50.4% overvalued | 58.6% | $1,532.0M | ($33.2M) | 54.9% | (2.2%) | 57.7% | (44.9%) | 54.2% | |
$13.9B | 6.2 | $147.2 74.8% undervalued | (37.1%) | $4,372.0M | $696.0M | (2.9%) | 15.9% | 65.4% | 34.6% | 93.8% |
FAQ
What is Thermo Fisher Scientific Inc. (TMO) stock rating?
As of today, Thermo Fisher Scientific Inc. has a stock rating of 6 (out of 10), which is considered Good.
is Thermo Fisher Scientific Inc. (TMO) a good stock to buy?
As of today, Thermo Fisher Scientific Inc. has a Good stock rating, which is 15.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.